Harvard Bioscience Inc
HBIO· Nasdaq
HBIOHarvard Bioscience Inc
Released May 4, 2022, before the open
10-Q filed May 4, 2022, 34 days after period end · 0001171843-22-003220
| Metric | Q1 2022 | Q1 2021 | Q1 2020 | Q1 2019 |
|---|---|---|---|---|
| Revenue | $28.78M | $26.99M | $23.77M | $28.20M |
| Net Income | -$6.88M | -$669.00K | -$4.52M | -$2.37M |
| EPS Diluted |
Harvard Bioscience Inc · CIK 1123494 · Engraved from SEC EDGAR
| -$0.17 |
| -$0.02 |
| -$0.12 |
| -$0.06 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
